Association between smoking and chronic kidney disease: A case control study

BMC Public Health

Volumn 10, Issue , 2010, Pages

  Yacoub, Rabi ^a   Habib, Habib ^b   Lahdo, Ayham ^d   Al Ali, Radwan ^d   Varjabedian, Leon ^a   Atalla, George ^d   Kassis Akl, Nader ^c   Aldakheel, Saleem ^d   Alahdab, Saeed ^d   Albitar, Sami ^d  

^a UNIVERSITY AT BUFFALO   (United States)

^b SETON HALL UNIVERSITY   (United States)

^c Jr Hospital of Cook County   (United States)

^d UNIVERSITY OF ALEPPO   (Syrian Arab Republic)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; CHRONIC KIDNEY FAILURE; CROSS-SECTIONAL STUDY; DIABETIC NEPHROPATHY; FEMALE; HUMAN; MALE; MIDDLE AGED; RENOVASCULAR HYPERTENSION; RISK ASSESSMENT; SMOKING;

ADOLESCENT; ADULT; AGED; CROSS-SECTIONAL STUDIES; DIABETIC NEPHROPATHIES; FEMALE; HUMANS; HYPERTENSION, RENAL; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; RISK ASSESSMENT; SMOKING; YOUNG ADULT;

EID: 78649333519     PISSN: None     EISSN: 14712458     Source Type: Journal    
DOI: 10.1186/1471-2458-10-731     Document Type: Article

References (42)

1. Tobacco, hypertension, and vascular disease: risk factors for renal functional decline in an older population. AJ Bleyer, et al. Kidney Int 2000 57 5 2072 9 10.1046/j.1523-1755.2000.00056.x 10792626
2. Risk factors for chronic kidney disease in a community-based population: a 10-year follow-up study. K Yamagata, et al. Kidney Int 2007 71 2 159 66 10.1038/sj.ki.5002017 17136030
3. Association between smoking and chronic renal failure in a nationwide population-based case-control study. E Ejerblad, et al. J Am Soc Nephrol 2004 15 8 2178 85 10.1097/01.ASN.0000135048.35659.10 15284303
4. Albuminuria reflects widespread vascular damage. The Steno hypothesis. T Deckert, et al. Diabetologia 1989 32 4 219 26 10.1007/BF00285287 2668076
5. Cigarette smoking increases the risk of albuminuria among subjects with type I diabetes. HP Chase, et al. JAMA 1991 265 5 614 7 10.1001/jama.265.5.614 1987411
6. Tobacco and end stage diabetic nephropathy. B Stegmayr F Lithner, Br Med J (Clin Res Ed) 1987 295 6598 581 2 10.1136/bmj.295.6598.581-a 3117242
7. A study of patients with diabetes mellitus (type 1) and end-stage renal failure: tobacco usage may increase risk of nephropathy and death. BG Stegmayr, J Intern Med 1990 228 2 121 4 10.1111/j.1365-2796.1990.tb00204.x 2394962
8. Similar rate of progression in the predialysis phase in type I and type II diabetes mellitus. G Biesenbach O Janko J Zazgornik, Nephrol Dial Transplant 1994 9 8 1097 102 7800207
9. Incidence of gross proteinuria in older-onset diabetes. A population-based perspective. R Klein BE Klein SE Moss, Diabetes 1993 42 3 381 9 10.2337/diabetes.42.3.381 8432408
10. Clinical prognostic factors in lupus nephritis. The importance of hypertension and smoking. MM Ward S Studenski, Arch Intern Med 1992 152 10 2082 8 10.1001/archinte.152.10.2082 1417382
11. Smoking as a risk factor for end-stage renal failure in men with primary renal disease. SR Orth, et al. Kidney Int 1998 54 3 926 31 10.1046/j.1523-1755. 1998.00067.x 9734618
12. Age, blood pressure and smoking effects on chronic renal failure in primary glomerular nephropathies. B Stengel, et al. Kidney Int 2000 57 6 2519 26 10844621
13. Elevated urinary excretion of beta-hexosaminidase in smokers. B Hultberg, et al. Eur J Clin Chem Clin Biochem 1992 30 3 131 3 1534692
14. Renal effects of cadmium body burden of the general population. JP Buchet, et al. Lancet 1990 336 8717 699 702 10.1016/0140-6736(90)92201-R 1975890
15. K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am J Kidney Dis 2002 39 2 Suppl 1 1 266 11904577
16. Evaluation of proteinuria. TS Larson, Mayo Clin Proc 1994 69 12 1154 8 7967776
17. Albuminuria in normals and essential hypertension. A Mimran, et al. J Diabetes Complications 1994 8 3 150 6 10.1016/1056-8727(94)90032-9 8086650
18. Cigarette smoking habits and urine characteristics: urinalysis abnormalities are more common is smokers, but the reasons are unclear. LG Dales, et al. Nephron 1978 20 3 167 70 10.1159/000181215 628498
19. Prevalence and risk factors for micro- and macroalbuminuria in an Italian population-based cohort of NIDDM subjects. G Bruno, et al. Diabetes Care 1996 19 1 43 7 10.2337/diacare.19.1.43 8720532
20. Risk of end-stage renal disease in diabetes mellitus: a prospective cohort study of men screened for MRFIT. Multiple Risk Factor Intervention Trial. FL Brancati, et al. JAMA 1997 278 23 2069 74 10.1001/jama.278.23.2069 9403420
21. End-stage renal disease in African-American and white men. 16-year MRFIT findings. MJ Klag, et al. JAMA 1997 277 16 1293 8 10.1001/jama.277.16.1293 9109467
22. Cigarette-smoking as a risk factor for macroproteinuria and proliferative retinopathy in type 1 (insulin-dependent) diabetes. I Muhlhauser P Sawicki M Berger, Diabetologia 1986 29 8 500 2 10.1007/BF00453501 3758532
23. Smoking habits and prevalence of clinical diabetic microangiopathy in insulin-dependent diabetics. S Telmer, et al. Acta Med Scand 1984 215 1 63 8 10.1111/j.0954-6820.1984.tb04970.x 6695564
24. Smoking is associated with progression of diabetic nephropathy. PT Sawicki, et al. Diabetes Care 1994 17 2 126 31 10.2337/diacare.17.2.126 8137682
25. Prospective study of risk factors for development of non-insulin dependent diabetes in middle aged British men. IJ Perry, et al. BMJ 1995 310 6979 560 4 7888929
26. The renal risks of smoking. SR Orth E Ritz RW Schrier, Kidney Int 1997 51 6 1669 77 10.1038/ki.1997.232 9186854
27. Overt proteinuria and microalbuminuria in autosomal dominant polycystic kidney disease. AB Chapman, et al. J Am Soc Nephrol 1994 5 6 1349 54 7894001
28. Cardiovascular risk factors and the long-term outcome of lupus nephritis. J Font, et al. QJM 2001 94 1 19 26 10.1093/qjmed/94.1.19 11161132
29. Renovascular disease in older patients beginning renal replacement therapy. RG Appel, et al. Kidney Int 1995 48 1 171 6 10.1038/ki.1995.281 7564074
30. A smoking-dependent risk of coronary artery disease associated with a polymorphism of the endothelial nitric oxide synthase gene. XL Wang, et al. Nat Med 1996 2 1 41 5 10.1038/nm0196-41 8564837
31. Primary glomerulonephritis and hydrocarbon exposure: a case-control study and literature review. M Yaqoob, et al. Q J Med 1992 83 301 409 18 1438676
32. Course and prognosis of anti-basement membrane antibody (anti-BM-Ab)-mediated disease: report of 35 cases. F Merkel, et al. Nephrol Dial Transplant 1994 9 4 372 6 8084449
33. Anti-GBM disease: predictive value of clinical, histological and serological data. M Herody, et al. Clin Nephrol 1993 40 5 249 55 8281713
34. Hemodynamic theory of progressive renal disease: a 10-year update in brief review. JR Neuringer BM Brenner, Am J Kidney Dis 1993 22 1 98 104 8322801
35. Progression of renal disease and renal hypertrophy. TH Hostetter, Annu Rev Physiol 1995 57 263 78 10.1146/annurev.ph.57.030195.001403 7778868
36. Actions of nicotine on renal function in dogs. WW Pawlik ED Jacobson RO Banks, Proc Soc Exp Biol Med 1985 178 4 585 90 3983135
37. Mechanism of effect of nicotine on renal water excretion. P Cadnapaphornchai, et al. Am J Physiol 1974 227 5 1216 20 4440764
38. Vasopressin and urinary concentration: additional risk factors in the progression of chronic renal failure. L Bankir N Bouby, Am J Kidney Dis 1991 17 5 Suppl 1 20 6 2024668
39. Non-nicotinized cigarettes and angina pectoris. WS Aronow AJ Swanson, Ann Intern Med 1969 70 6 1227 5789511
40. Carboxyhemoglobin caused by smoking nonnicotine cigarettes. Effects in angina pectoris. WS Aronow SN Rokaw, Circulation 1971 44 5 782 8 5115069
41. Heart rate and carbon monoxide level after smoking high-, low-, and non-nicotine cigarettes. A study in male patients with angina pectoris. WS Aronow J Dendinger SN Rokaw, Ann Intern Med 1971 74 5 697 702 5559433
42. Interference with renal organic cation transport by (-)- and (+)-nicotine at concentrations documented in plasma of habitual tobacco smokers. LT Wong DD Smyth DS Sitar, J Pharmacol Exp Ther 1992 261 1 21 5 1560368